In addition, patients with the tumour on the left hemisphere of the brain and in the parietal lobe with the presence of MGMT and IDH had reduced overall survival; however, this reduction in overall survival was not statistically significant (p > 0.05, Table 1). The gene discussed is MGMT; the disease is neoplasm.